Resource Summary

Clinical Question:
Which puffer has the greatest impact on clinical outcomes as the first-line long- acting inhaled treatment for COPD?

Bottom-line:
The available evidence indicates that tiotropium is likely the best
initial long-acting therapy for COPD^ followed by a LABA (like salmeterol).



*** Original Documents can be found and downloaded using the link provided below ***

https://www.acfp.ca/tools-for-practice/

Publication Date: 2012-4-30
Last Updated on PCR: 2017-04-01 11:19:35